These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31038317)

  • 1. Horisfieldones A and B, Two Aromatic Ring-Contracted Dimeric Diarylpropanes with Human DOPA Decarboxylase Inhibitory Activity from Horsfieldia kingii.
    Zhan R; Hu YT; Shao LD; Qin XJ; Kuang F; Du SZ; Wu F; Chen YG
    Org Lett; 2019 May; 21(10):3678-3681. PubMed ID: 31038317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive diarylpropane dimer and spirocyclic-monomers from Horsfieldia kingii.
    Wang CF; Liu Y; Du SZ; Chen YG; Zhan R
    Bioorg Chem; 2023 May; 134():106438. PubMed ID: 36848715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarylpropanes from
    Liu B; Chen YG; Tian XJ; Zhan R
    Nat Prod Res; 2021 Apr; 35(7):1127-1133. PubMed ID: 31322421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb.
    Ren J; Zhang Y; Jin H; Yu J; Zhou Y; Wu F; Zhang W
    ACS Chem Biol; 2014 Apr; 9(4):897-903. PubMed ID: 24471650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diarylpropanes and an arylpropyl quinone from Combretum griffithii.
    Moosophon P; Kanokmedhakul S; Kanokmedhakul K
    J Nat Prod; 2011 Oct; 74(10):2216-8. PubMed ID: 21919533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian Dopa decarboxylase: structure, catalytic activity and inhibition.
    Bertoldi M
    Arch Biochem Biophys; 2014 Mar; 546():1-7. PubMed ID: 24407024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase. Effects on catalytic properties.
    Bertoldi M; Castellani S; Bori Voltattorni C
    Eur J Biochem; 2001 May; 268(10):2975-81. PubMed ID: 11358515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase.
    Bertoldi M; Gonsalvi M; Voltattorni CB
    Biochem Biophys Res Commun; 2001 Jun; 284(1):90-3. PubMed ID: 11374875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asperversins A and B, Two Novel Meroterpenoids with an Unusual 5/6/6/6 Ring from the Marine-Derived Fungus
    Li H; Sun W; Deng M; Qi C; Chen C; Zhu H; Luo Z; Wang J; Xue Y; Zhang Y
    Mar Drugs; 2018 May; 16(6):. PubMed ID: 29882867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new lignans from Horsfieldia kingii.
    Liu B; Du SZ; Kuang F; Liu Y; Tian XJ; Chen YG; Zhan R
    Nat Prod Res; 2019 Jan; 33(1):95-100. PubMed ID: 29447479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
    Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
    Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine).
    Bertoldi M; Voltattorni CB
    Protein Sci; 2001 Jun; 10(6):1178-86. PubMed ID: 11369856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.
    Horley NJ; Beresford KJM; Kaduskar S; Joshi P; McCann GJP; Ruparelia KC; Williams IS; Gatchie L; Sonawane VR; Bharate SB; Chaudhuri B
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5409-5414. PubMed ID: 29138024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrostilbenes and diarylpropanes: Synthesis and in vitro pharmacological evaluation as potent nitric oxide production inhibition agents.
    Jang HY; Park HJ; Damodar K; Kim JK; Jun JG
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5438-5443. PubMed ID: 27777005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new dimeric diarylpropane from Horsfieldia tetratepala.
    Du SZ; Kuang F; Liu Y; Chen YG; Zhan R
    Nat Prod Res; 2018 Jan; 32(2):162-166. PubMed ID: 28641463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation, unfolding and refolding trials of pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase.
    Dominici P; Moore PS; Borri Voltattorni C
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):493-500. PubMed ID: 8240248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
    Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
    Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.
    Cheng P; Zhou J; Qing Z; Kang W; Liu S; Liu W; Xie H; Zeng J
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2712-6. PubMed ID: 24794108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases.
    Maras B; Dominici P; Barra D; Bossa F; Voltattorni CB
    Eur J Biochem; 1991 Oct; 201(2):385-91. PubMed ID: 1935935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
    Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
    Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.